Atossa Therapeutics Announces Fourth Quarter and Year End 2019 Financial Results and Provides Company Update
SEATTLE, March 26, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and […]